New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Clinical trial NCT00035269 · COMPLETED

Trial details

NCT number: NCT00035269
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumonia, Pneumococcal Community Acquired Infections Gram-positive Bacterial Infections

Start date: 2001-12-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.